The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Blood Lead, Bone Turnover, and Survival in Amyotrophic Lateral Sclerosis
Abstract
Blood lead and bone turnover may be associated with the risk of amyotrophic lateral sclerosis (ALS). We aimed to assess whether these factors were also associated with time from ALS diagnosis to death through a survival analysis of 145 ALS patients enrolled during 2007 in the National Registry of Veterans with ALS. Associations of survival time with blood lead and plasma biomarkers of bone resorption (C-terminal telopeptides of type I collagen (CTX)) and bone formation (procollagen type I amino-terminal peptide (PINP)) were estimated using Cox models adjusted for age at diagnosis, diagnostic certainty, diagnostic delay, site of onset, and score on the Revised ALS Functional Rating Scale. Hazard ratios were calculated for each doubling of biomarker concentration. Blood lead, plasma CTX, and plasma PINP were mutually adjusted for one another. Increased lead (hazard ratio (HR) = 1.38; 95% confidence interval (CI): 1.03, 1.84) and CTX (HR = 2.03; 95% CI: 1.42, 2.89) were both associated with shorter survival, whereas higher PINP was associated with longer survival (HR = 0.59; 95% CI: 0.42, 0.83), after ALS diagnosis. No interactions were observed between lead or bone turnover and other prognostic indicators. Lead toxicity and bone metabolism may be involved in ALS pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bone lead levels have been reported to be higher in ALS patients.”
From Risk factors for amyotrophic lateral sclerosis: A regional United States case‐control study (2021) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hypovitaminosis D and Decreased Bone Mineral Density in Amyotrophic Lateral Sclerosis
Sato, Y., Honda, Y., Asoh, T., Kikuyama, M., & Ōizumi, K. (2008) · European Neurology · doi:10.1159/000117447 · Cited by 60
RetractedEl Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression
Vittinghoff, E., & McCulloch, C. E. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk052 · Cited by 4,359
Causal Diagrams for Epidemiologic Research
Greenland, S., Pearl, J., & Robins, J. M. (1999) · Epidemiology · doi:10.1097/00001648-199901000-00008 · Cited by 3,728
Air Pollution and Hospital Admissions for Heart Disease in Eight U.S. Counties
Schwartz, J. (1999) · Epidemiology · doi:10.1097/00001648-199901000-00005 · Cited by 3,038
Applied Survival Analysis: Regression Modeling of Time-to-Event Data
Hosmer, D. W., Lemeshow, S. A., & May, S. J. (2008) · Cited by 3,030
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
Maternal Pesticide Exposure from Multiple Sources and Selected Congenital Anomalies
Shaw, G. M., Wasserman, C. R., OʼMalley, C. D., Nelson, V., & Jackson, R. J. (1999) · Epidemiology · doi:10.1097/00001648-199901000-00011 · Cited by 1,784
Immortal Time Bias in Pharmacoepidemiology
Suissa, S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm324 · Cited by 1,708
Concato, J., Peduzzi, P., Holford, T. R., & Feinstein, A. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00510-2 · Cited by 797
Energy metabolism in amyotrophic lateral sclerosis
Dupuis, L., Pradat, P.-F., Ludolph, A. C., & Loeffler, J.-P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70224-6 · Cited by 537
Prognosis in amyotrophic lateral sclerosis: A population-based study
del Aguila, M. A., Longstreth, W. T., McGuire, V., Koepsell, T. D., & van Belle, G. (2003) · Neurology · doi:10.1212/01.wnl.0000049472.47709.3b · Cited by 469
Early symptom progression rate is related to ALS outcome: A prospective population-based study
Chiò, A., Mora, G., Leone, M., Mazzini, L., Cocito, D., Giordana, M. T., Bottacchi, E., & Mutani, R. (2002) · Neurology · doi:10.1212/wnl.59.1.99 · Cited by 266
Long‐term survival in amyotrophic lateral sclerosis: A population‐based study
Pupillo, E., Messina, P., Logroscino, G., Beghi, E., & the SLALOM Group (2014) · Annals of Neurology · doi:10.1002/ana.24096 · Cited by 205
Lead Exposure and Amyotrophic Lateral Sclerosis
Kamel, F., Umbach, D. M., Munsat, T. L., Shefner, J. M., Hu, H., & Sandler, D. P. (2002) · Epidemiology · doi:10.1097/00001648-200205000-00012 · Cited by 174
Self-citationMcCully, K. S. (2009) · PubMed · Cited by 152
Survival of Patients with Amyotrophic Lateral Sclerosis in a Population-Based Registry
Millul, A., Beghi, E., Logroscino, G., Micheli, A., Vitelli, E., & Zardi, A. (2005) · Neuroepidemiology · doi:10.1159/000086353 · Cited by 140
Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm
Elamin, M., Bede, P., Montuschi, A., Pender, N. P., Chiò, A., & Hardiman, O. M. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7731-6 · Cited by 128
Lead Exposure as a Risk Factor for Amyotrophic Lateral Sclerosis
Kamel, F., Umbach, D. M., Hu, H., Munsat, T. L., Shefner, J. M., Taylor, J. A., & Sandler, D. P. (2005) · Neurodegenerative Diseases · doi:10.1159/000089625 · Cited by 125
Self-citationThe role of homocysteine in bone remodeling
Vacek, T. P., Kalani, A., Voor, M. J., Tyagi, S. C., & Tyagi, N. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0605 · Cited by 122
Association Between Blood Lead and the Risk of Amyotrophic Lateral Sclerosis
Fang, F., Kwee, L. C., Allen, K. D., Umbach, D. M., Ye, W., Watson, M., Keller, J., Oddone, E. Z., Sandler, D. P., Schmidt, S., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq063 · Cited by 121
Self-citationHu, H., Payton, M., Kornc, S., Aro, A., Sparrow, D., Weiss, S. T., & Rotnitzky, A. G. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008999 · Cited by 111
Nash, D., Magder, L. S., Sherwin, R., Rubin, R. J., & Silbergeld, E. K. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh296 · Cited by 110
Beier, E. E., Maher, J. R., Sheu, T., Cory‐Slechta, D. A., Berger, A. J., Zuscik, M. J., & Puzas, J. E. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1205374 · Cited by 104
Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole
Paillisse, C., Lacomblez, L., Dib, M., Bensimon, G., Garcia-Acosta, S., & Meininger, V. (2005) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820510027035 · Cited by 104
Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis
Turner, M. R., Bakker, M., Sham, P. C., Shaw, C., Leigh, P. N., & Al‐Chalabi, A. (2002) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608202317576499 · Cited by 97
Camu, W., Tremblier, B., Plassot, C., Alphandery, S., Salsac, C., Pageot, N., Juntas-Morales, R., Scamps, F., Daures, J.-P., & Raoul, C. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.005 · Cited by 95
The Association between Environmental Lead Exposure and Bone Density in Children
Campbell, J. R., Rosier, R. N., Novotny, L., & Puzas, J. E. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6555 · Cited by 92
Blood Lead Is a Predictor of Homocysteine Levels in a Population-Based Study of Older Adults
Schafer, J. H., Glass, T. A., Bressler, J. P., Todd, A. C., & Schwartz, B. S. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.7369 · Cited by 80
Amyotrophic lateral sclerosis: all roads lead to Rome
de Aguilar, J. G., Echaniz‐Laguna, A., Fergani, A., René, F., Meininger, V., Loeffler, J., & Dupuis, L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04408.x · Cited by 80
Kamel, F., Umbach, D. M., Lehman, T. A., Park, L. P., Munsat, T. L., Shefner, J. M., Sandler, D. P., Hu, H., & Taylor, J. A. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6109 · Cited by 78
Self-citationVitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis
Karam, C., Barrett, M. J., Imperato, T., MacGowan, D. J. L., & Scelsa, S. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.01.011 · Cited by 74
Escribano, A., Revilla, M., Hernández, E. R., Seco, C., González-Riola, J., Villa, L. F., & Rico, H. (1997) · Calcified Tissue International · doi:10.1007/s002239900214 · Cited by 71
Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis
Lewis, C. M., & Suzuki, M. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt421 · Cited by 66
Homocysteine levels and amyotrophic lateral sclerosis: A possible link
Zoccolella, S., Bendotti, C., Beghi, E., & Logroscino, G. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960902919360 · Cited by 64
Tsaih, S., Korrick, S., Schwartz, J., Lee, M. T., Amarasiriwardena, C. J., Aro, A., Sparrow, D., & Hu, H. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109995 · Cited by 61
Predictability of disease progression in amyotrophic lateral sclerosis
Czapliński, A., Yen, A. A., Simpson, E. P., & Appel, S. H. (2006) · Muscle & Nerve · doi:10.1002/mus.20658 · Cited by 54
The National Registry of Veterans with Amyotrophic Lateral Sclerosis
Allen, K. D., Kasarskis, E. J., Bedlack, R., Rozear, M. P., Morgenlander, J. C., Sabet, A., Sams, L., Lindquist, J. H., Harrelson, M., Coffman, C. J., et al. (2008) · Neuroepidemiology · doi:10.1159/000126910 · Cited by 51
Self-citationDefining Survival as an Outcome Measure in Amyotrophic Lateral Sclerosis
Gordon, P. H., Corcia, P., Lacomblez, L., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.1 · Cited by 51
Association of Lead Exposure with Survival in Amyotrophic Lateral Sclerosis
Kamel, F., Umbach, D. M., Stallone, L., Richards, M., Hu, H., & Sandler, D. P. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11193 · Cited by 46
Self-citationŁukaszewicz‐Zając, M., Mroczko, B., & Słowik, A. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1205-3 · Cited by 45
Primary hyperparathyroidism and ALS: Is there a relation?
Jackson, C. E., Amato, A. A., Bryan, W. W., Wolfe, G. I., Sakhaee, K., & Barohn, R. J. (1998) · Neurology · doi:10.1212/wnl.50.6.1795 · Cited by 43
Gianforcaro, A., & Hamadeh, M. J. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00316.x · Cited by 42
Berry, P., Maciewicz, R. A., Cicuttini, F., JONES, M. D., Hellawell, C. J., & Wluka, A. E. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091055 · Cited by 42
Hu, H., Payton, Korrick, & Aro (1996) · American Journal of Epidemiology · Cited by 29
Calcium metabolism in amyotrophic lateral sclerosis.
Mallette, L. E., Patten, B. M., Cook, J. D., & Engel, W. K. (1977) · PubMed · Cited by 20
Guiloff, R. J., & Goonetilleke, A. (1995) · PubMed · Cited by 16
ALSUntangled No. 24: Vitamin D
The ALSUntangled Group (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.888871 · Cited by 6
Cited by
Risk factors for amyotrophic lateral sclerosis: A regional United States case‐control study
Andrew, A. S., Bradley, W. G., Peipert, D., Butt, T., Amoako, K., Pioro, E. P., Tandan, R., Novak, J., Quick, A., Pugar, K. D., et al. (2021) · Muscle & Nerve · doi:10.1002/mus.27085 · Cited by 54
Metadata
- Authors
- Fang, F., Peters, T. L., Beard, J. D., Umbach, D. M., Keller, J., Mariosa, D., Allen, K. D., Ye, W., Sandler, D. P., Schmidt, S., & Kamel, F.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-08-23
- Volume
- 186
- Issue
- 9
- Pages
- 1057-1064
- ISSN
- 0002-9262
- 1476-6256
- Cited by
- 15
- References
- 48
- Language
- en
- Funders
- National Institutes of Health
- National Institute of Environmental Health Sciences
- National Institutes of Health, National Institute of Environmental Health Sciences (Z01-ES-049005)
- National Institute of Environmental Health Sciences/National Institutes of Health (R01-ES-013244)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.